Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
This review explores novel small molecule drug design strategies for treating diverse human diseases. It covers chemogenomics, chemokine networks, and enzyme-based therapies for targeted treatment and disease correction.
Area of Science:
Pharmacology and Medicinal Chemistry
Biotechnology
Computational Biology
Context:
Small molecule compounds are crucial for developing highly specific therapies.
Pathophysiological conditions in humans often share common mediators and development processes.
Emerging technologies offer new avenues for drug design and disease correction.
Purpose:
To review literature data and author findings on perspective technologies for designing active chemical and natural compounds.
To discuss strategies for developing small molecule-based therapies for various pathophysiological conditions.
To highlight the potential of novel approaches in precision medicine.
Summary:
Discusses chemogenomics for computer-aided small molecule screening.
Explores chemokine networks for controlling inflammation, viral infections, and cancer.
Details the use of cytochrome P450 enzymes for drug bioavailability and safety.
Covers superoxide dismutase enzymes for tissue injury and inflammation.
Addresses telomere maintenance for anticancer, antiviral, and aging process correction.
Includes short interfering RNAs for inducing intracellular immunity.
Impact:
Provides a comprehensive overview of cutting-edge drug design strategies.
Identifies potential therapeutic targets and approaches for complex diseases.
Facilitates the development of more effective and safer treatments.
Offers insights into personalized medicine and disease management.